On Thursday, Shares of Cabot Oil & Gas Corporation (NYSE:COG), subtract -4.65% and closed at $22.75 in the last trading session. The last trading range of the stock ranges between $22.19 and $24.17. Cabot Oil & Gas Corporation (COG) (“Cabot” or the “Company”) recently declared that the Federal Energy Regulatory Commission (“FERC”) issued a letter announcing that it is evaluating certain alternatives to the Central Penn Line North and South routes, which are portions of the Atlantic Sunrise Project. The two alternative routes that are being evaluated include a potential 1.4 mile deviation, in aggregate, from the presently projected route. Comments from the affected landowners regarding the alternative routes are due no later than November 14, 2016. Cabot anticipates that the FERC will issue an updated Notice of Plan in a timely manner, which should address the updated timeline for the issuance of the Final Environmental Impact Statement.
Gold Fields Limited (ADR) (NYSE:GFI), jumped 3.94% and closed at $4.22 in the last trading session. The last trading range of the stock ranges between $4.07 and $4.44. The company’s Market capitalization is $3.41 Billion with the total Outstanding Shares of 821.53 million. Gold Fields Limited produces gold and holds gold reserves in South Africa, Ghana, Australia, and Peru. It engages in underground and surface gold and surface copper mining and related activities, counting exploration, extraction, processing, and smelting. The company holds interests in eight operating mines with an annual gold production of about 2.16 million ounces, in addition to mineral reserves of about 46 million ounces and mineral resources of about 102 million ounces. It also produces copper in Peru and holds attributable copper mineral reserves totaling 532 million pounds and mineral resources totaling 910 million pounds.
Array Biopharma Inc (NASDAQ:ARRY), jumped 3.19% and closed at $6.80 in the last trading session. The last trading range of the stock ranges between $6.48 and $6.84. During the 52-week trading session the minimum price at which share price traded, registered at $2.38and reached to max level of $7.27. – Array BioPharma Inc. (ARRY) declared recently the closing of its underwritten public offering of 21,160,000 shares of its common stock, which includes 2,760,000 shares of common stock issued upon the exercise in full of the option to purchase additional shares granted to the underwriters, at a public offering price of $6.25 per share. The total gross proceeds from the offering are $132.25 million, before underwriting discounts and commissions and offering expenses.
J.P. Morgan Securities LLC and Cowen and Company, LLC acted as joint book-running managers for the offering. Stifel and Wells Fargo Securities, LLC acted as lead managers and SunTrust Robinson Humphrey, Inc. acted as co-manager.
The shares were sold following an effective shelf registration statement filed with the Securities and Exchange Commission (the “SEC”). This press release does not constitute an offer to sell, or the solicitation of an offer to buy, these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted.